SB2960 mandates coverage for lung cancer screenings and biomarker tests in Illinois health insurance policies.
SB2960 amends various Illinois codes to require health insurance policies to cover medically necessary lung cancer screenings and biomarker tests, including anaplastic lymphoma kinase (ALK). This applies to policies amended, delivered, issued, or renewed on or after January 1, 2028. The bill affects the State Employees Group Insurance Act, Counties Code, Illinois Municipal Code, School Code, Health Maintenance Organization Act, and Illinois Public Aid Code. The Department of Insurance enforces these requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.